US regulator imposes conditions on Sun's Ranbaxy acquisition
Jan 31, 2015, 07:13 AM ISTWashington: An American federal trade regulator today imposed conditions on Sun Pharmaceuticals' acquisition of Ranbaxy on the grounds that the USD 4 billion proposed deal would likely be anti-competitive.The Federal Trade Commission (FTC) said pharmaceutical